Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897046703> ?p ?o ?g. }
- W2897046703 endingPage "e653" @default.
- W2897046703 startingPage "e652" @default.
- W2897046703 abstract "Optimal adjuvant treatment of FIGO stage II endometrial cancer is controversial. As surgical practice evolves to include nodal resection, there may be a role for de-intensifying adjuvant therapy. In this province-wide retrospective review, patterns of recurrence were analyzed, alongside adjuvant radiotherapy (RT) practices including pelvic external beam (EB) RT, vaginal vault brachytherapy (BT), and small “minipelvis” (MP) EBRT fields, covering surgical bed, vaginal vault, and parametria, but not the classic elective nodal volumes. We identified patients diagnosed with stage II endometrial cancer between 2000-2014 who received adjuvant RT in Alberta, Canada. We collected demographics, disease characteristics, treatment details, and clinical outcomes. Recurrence-free survival (RFS) was calculated by Kaplan-Meier analysis and factors associated with recurrence were determined by univariate and multivariate analysis. A total of 264 patients (median age 62 [35-87]) met inclusion criteria. 83% had endometrioid adenocarcinoma, 25% grade 3 disease, 56% outer half myometrial invasion, and 44% lymphovascular invasion (LVI). Nodes were surgically assessed in half: 130 (49%) pelvic and 26 (10%) para-aortic. 34 patients (13%) had chemotherapy. RT was predominantly full pelvis (FP) EBRT+BT (114), but included BT alone (63), FP-EBRT alone (42), MP-EBRT+BT (34), and MP-EBRT alone (11). 5 year RFS for the entire cohort was 87%, with median follow-up 93.0 months [5.0-212.7]. 57 patients recurred (22%), including 25% of those treated with FP-EBRT+BT, 16% receiving BT alone, 14% receiving FP-EBRT alone, 21% receiving MP-EBRT+BT, and 55% receiving MP-EBRT alone. On multivariate analysis (reference: FP-EBRT+BT), no treatment group was significantly associated with recurrence. A trend was seen for MP-EBRT alone (hazard ratio [HR] 4.25, p=0.052). Mixed histology and presence of LVI were associated with recurrence (HR 3.73, p=0.008; and HR 3.38, p=0.001, respectively). Chemotherapy was protective (HR 0.20, p=0.012). Pathologic nodal assessment was not correlated with recurrence (p=0.90). Median time to recurrence was 19.9 months [2.9-92.3]. Recurrence was locoregional-only (not para-aortic nor distant) for a minority of patients (N=19/57, 33%), comparable for FP-EBRT+BT (N=8, 7.0%) and MP-EBRT+BT (N=3, 8.8%) groups. Among all patients, 62 (24%) had recorded late toxicity, most frequently gastrointestinal (N=40), including grade 3-4 (N=3) and grade 5 (N=2), with all grades 3-5 having received FP-EBRT+/-BT. No single best adjuvant treatment strategy exists for stage II endometrial cancer. Careful risk stratification is suggested in selecting optimal adjuvant treatment. MP-EBRT+BT is an option for local treatment of the surgical bed, vaginal vault, and parametria, with potential to decrease toxicity." @default.
- W2897046703 created "2018-10-26" @default.
- W2897046703 creator A5008398772 @default.
- W2897046703 creator A5014419741 @default.
- W2897046703 creator A5018059259 @default.
- W2897046703 creator A5021089805 @default.
- W2897046703 creator A5026431612 @default.
- W2897046703 creator A5026765226 @default.
- W2897046703 creator A5028408259 @default.
- W2897046703 creator A5029363019 @default.
- W2897046703 creator A5040571393 @default.
- W2897046703 creator A5050306632 @default.
- W2897046703 creator A5070151942 @default.
- W2897046703 creator A5086056195 @default.
- W2897046703 date "2018-11-01" @default.
- W2897046703 modified "2023-09-27" @default.
- W2897046703 title "Patterns of Recurrence By Adjuvant Radiation Therapy Type for Stage II Endometrial Cancer: A Provincial Review" @default.
- W2897046703 doi "https://doi.org/10.1016/j.ijrobp.2018.07.1771" @default.
- W2897046703 hasPublicationYear "2018" @default.
- W2897046703 type Work @default.
- W2897046703 sameAs 2897046703 @default.
- W2897046703 citedByCount "0" @default.
- W2897046703 crossrefType "journal-article" @default.
- W2897046703 hasAuthorship W2897046703A5008398772 @default.
- W2897046703 hasAuthorship W2897046703A5014419741 @default.
- W2897046703 hasAuthorship W2897046703A5018059259 @default.
- W2897046703 hasAuthorship W2897046703A5021089805 @default.
- W2897046703 hasAuthorship W2897046703A5026431612 @default.
- W2897046703 hasAuthorship W2897046703A5026765226 @default.
- W2897046703 hasAuthorship W2897046703A5028408259 @default.
- W2897046703 hasAuthorship W2897046703A5029363019 @default.
- W2897046703 hasAuthorship W2897046703A5040571393 @default.
- W2897046703 hasAuthorship W2897046703A5050306632 @default.
- W2897046703 hasAuthorship W2897046703A5070151942 @default.
- W2897046703 hasAuthorship W2897046703A5086056195 @default.
- W2897046703 hasBestOaLocation W28970467031 @default.
- W2897046703 hasConcept C121608353 @default.
- W2897046703 hasConcept C126322002 @default.
- W2897046703 hasConcept C126838900 @default.
- W2897046703 hasConcept C126894567 @default.
- W2897046703 hasConcept C141071460 @default.
- W2897046703 hasConcept C143998085 @default.
- W2897046703 hasConcept C144301174 @default.
- W2897046703 hasConcept C146357865 @default.
- W2897046703 hasConcept C151730666 @default.
- W2897046703 hasConcept C167135981 @default.
- W2897046703 hasConcept C2775908122 @default.
- W2897046703 hasConcept C2777088508 @default.
- W2897046703 hasConcept C2777416452 @default.
- W2897046703 hasConcept C2777982462 @default.
- W2897046703 hasConcept C2778560750 @default.
- W2897046703 hasConcept C2778740770 @default.
- W2897046703 hasConcept C2779013556 @default.
- W2897046703 hasConcept C2779494336 @default.
- W2897046703 hasConcept C38180746 @default.
- W2897046703 hasConcept C50382708 @default.
- W2897046703 hasConcept C509974204 @default.
- W2897046703 hasConcept C71924100 @default.
- W2897046703 hasConcept C86803240 @default.
- W2897046703 hasConceptScore W2897046703C121608353 @default.
- W2897046703 hasConceptScore W2897046703C126322002 @default.
- W2897046703 hasConceptScore W2897046703C126838900 @default.
- W2897046703 hasConceptScore W2897046703C126894567 @default.
- W2897046703 hasConceptScore W2897046703C141071460 @default.
- W2897046703 hasConceptScore W2897046703C143998085 @default.
- W2897046703 hasConceptScore W2897046703C144301174 @default.
- W2897046703 hasConceptScore W2897046703C146357865 @default.
- W2897046703 hasConceptScore W2897046703C151730666 @default.
- W2897046703 hasConceptScore W2897046703C167135981 @default.
- W2897046703 hasConceptScore W2897046703C2775908122 @default.
- W2897046703 hasConceptScore W2897046703C2777088508 @default.
- W2897046703 hasConceptScore W2897046703C2777416452 @default.
- W2897046703 hasConceptScore W2897046703C2777982462 @default.
- W2897046703 hasConceptScore W2897046703C2778560750 @default.
- W2897046703 hasConceptScore W2897046703C2778740770 @default.
- W2897046703 hasConceptScore W2897046703C2779013556 @default.
- W2897046703 hasConceptScore W2897046703C2779494336 @default.
- W2897046703 hasConceptScore W2897046703C38180746 @default.
- W2897046703 hasConceptScore W2897046703C50382708 @default.
- W2897046703 hasConceptScore W2897046703C509974204 @default.
- W2897046703 hasConceptScore W2897046703C71924100 @default.
- W2897046703 hasConceptScore W2897046703C86803240 @default.
- W2897046703 hasIssue "3" @default.
- W2897046703 hasLocation W28970467031 @default.
- W2897046703 hasOpenAccess W2897046703 @default.
- W2897046703 hasPrimaryLocation W28970467031 @default.
- W2897046703 hasRelatedWork W1992803488 @default.
- W2897046703 hasRelatedWork W1994750039 @default.
- W2897046703 hasRelatedWork W2069132912 @default.
- W2897046703 hasRelatedWork W2079856228 @default.
- W2897046703 hasRelatedWork W2394705251 @default.
- W2897046703 hasRelatedWork W2411961033 @default.
- W2897046703 hasRelatedWork W2898451845 @default.
- W2897046703 hasRelatedWork W2993575405 @default.
- W2897046703 hasRelatedWork W3023151437 @default.
- W2897046703 hasRelatedWork W4295234634 @default.
- W2897046703 hasVolume "102" @default.
- W2897046703 isParatext "false" @default.